News and Announcements
Wholesale Investor Set to Take on New York and London
- Published August 25, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Wholesale Investor is pleased to announce that we are going to New York for the first time, bringing with us Australasia’s leading emerging growth companies for a special investor event co-hosted with DLA Piper, the New York Australasian Emerging Company Showcase on 27th of October 2017.
The New York event is part of our Australasian Emerging Company roadshow tour which also includes an investor event in London on 23rd of October 2017.
The international investor events, are part of our growing commitment to provide Australasia’s emerging companies and startups with access to international markets and high net worth investors from around the globe.
Wholesale Investor’s Managing Director, Steve Torso, spoke out about this new move. “We are excited about this new direction that Wholesale Investor is heading in. Across October and November, we are hosting 6 events, across 6 countries (Australia, UK, US, Singapore, Hong Kong and Korea) in 3 weeks! We are one of the first companies in this space to do this. As US & Asia close the gap in VC funding, it has never been a better time for companies seeking to raise capital or profile to investors, to tap into these markets.”
In 2017, Wholesale Investor has already hosted 25+ events across Australia, Singapore and UK with more than 4,800 investors registered, resulting in 3,200+ enquiries into client companies. Wholesale Investor has now crossed 17,200+ global investor network and 360+ clients.
Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
